NCT06219967

Brief Summary

Activated charcoal (AC) is an established, effective means of gastrointestinal decontamination. Providers give it to patients who have ingested something that is thought to be potentially poisonous to prevent it from being absorbed. However, one limitation to its use is palatability of the AC for the patient, potentially limiting how much, if any, is taken. Other studies have suggested that mixing AC with various substances improves the rating on various scales (taste, etc). An important question is whether mixing the AC with other substance effects the ability of the AC to bind to xenobiotic in the gut. This small study investigates whether mixed cola with charcoal affected its ability to prevent the absorption of acetaminophen. It also performs a survery to see if participants preferred the AC-cola mixture. The investigators hypothesize that the AC will be equally as effective with cola as without. The investigators also hypothesize that participants will prefer the AC-cola mixture.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jan 2023

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 4, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
4 months until next milestone

Results Posted

Study results publicly available

May 30, 2024

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

January 2, 2024

Results QC Date

March 12, 2024

Last Update Submit

May 3, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Absorption of Acetaminophen as Indicated by Area Under the Curve

    Measure of the area under the curve of the acetaminophen concentration vs time curve. Values obtained at 0, 15, 30, 45, 60, 75, 90, 120, 180, and 240 minutes were used to produce the curve

    240 minutes

  • Maximum Concentration Acetaminophen

    Maximum concentration of acetaminophen (mcg/mL)

    240 minutes

  • Time to Maximum Concentration of Acetaminophen

    Time of maximum concentration of acetaminophen (minutes)

    240 minutes

Secondary Outcomes (5)

  • Appeal of Charcoal Mixture

    5 minutes

  • Smell of Charcoal Mixture

    5 minutes

  • Flavor of Charcoal Mixture

    5 minutes

  • Texture of Charcoal Mixture

    5 minutes

  • Overall Appeal of Charcoal Mixture

    5 minutes

Study Arms (2)

Activated charcoal with cola

EXPERIMENTAL
Drug: Activated Charcoal

Activated charcoal

ACTIVE COMPARATOR
Drug: Activated Charcoal

Interventions

Activated charcoal alone

Activated charcoal

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • No self-reported history of any hepatic, gastrointestinal, or renal disease
  • No self-reported history of alcohol or substance use disorder
  • No daily prescribed medications
  • Weight between 60-93 kg

You may not qualify if:

  • pregnant,
  • imprisoned
  • allergy or intolerance to acetaminophen or gluten

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUNY Upstate Medical University Clinical Research Unit

Syracuse, New York, 13210, United States

Location

MeSH Terms

Conditions

Drug Overdose

Interventions

Charcoal

Condition Hierarchy (Ancestors)

Prescription Drug MisuseDrug MisuseSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

CarbonElementsInorganic Chemicals

Results Point of Contact

Title
Michael Keenan, MD
Organization
SUNY Upstate Department of Emergency Medicine

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor Emergency Medicine

Study Record Dates

First Submitted

January 2, 2024

First Posted

January 23, 2024

Study Start

January 4, 2023

Primary Completion

March 14, 2023

Study Completion

March 14, 2023

Last Updated

May 30, 2024

Results First Posted

May 30, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations